Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|March 6, 2023
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literatureLisa L Liu, Marcus Skribek, Ulrika Harmenberg, et al.
Scandinavian Journal of Urology|July 24, 2015
Impact of quality indicators on adherence to National and European guidelines for renal cell carcinomaAndreas Thorstenson, Ulrika Harmenberg, Per Lindblad, et al.
BJUI Compass|January 1, 2026
Real-world drivers of treatment choices in synchronous metastatic renal cell carcinomaTarik Almdalal, Maja Fahlén, Ulrika Harmenberg, et al.
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Curative radiation therapy in prostate cancerUlrika Harmenberg, Freddie C Hamdy, Anders Widmark, et al.
Biomed Research International|November 6, 2015
Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in SwedenAndreas Thorstenson, Ulrika Harmenberg, Per Lindblad, et al.
World Journal of Urology|February 6, 2016
Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based studySaeed Dabestani, Andreas Thorstenson, Per Lindblad, et al.
Cancer Immunology, Immunotherapy : CII|May 16, 2002
Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinomaSzilvia Mosolits, Michael Steinitz, Ulrika Harmenberg, et al.
Acta Oncologica (Stockholm, Sweden)|December 4, 2018
Metastatic papillary renal cell carcinoma in the era of targeted therapy - a retrospective study from three European academic centresMaria Stenman, Michael Staehler, Bernadett Szabados, et al.
Scandinavian Journal of Urology|May 22, 2020
The renal cell cancer database Sweden (RCCBaSe) - a new register-based resource for renal cell carcinoma researchAnna Landberg, Per Lindblad, Ulrika Harmenberg, et al.
Urologic Oncology|June 18, 2017
Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002 to 2012: Update of the RENCOMP study with subgroup analysis of the synchronous metastatic and elderly populationsMagnus Lindskog, Thomas Wahlgren, Rickard Sandin, et al.
Pageof 4